|
1
|
Ranganathan K and Sivasankar V:
MicroRNAs-biology and clinical applications. J Oral Maxillofac
Pathol. 18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pileczki V, Cojocneanu-Petric R, Maralani
M, Neagoe IB and Sandulescu R: MicroRNAs as regulators of apoptosis
mechanisms in cancer. Clujul Med. 89:50–55. 2016.PubMed/NCBI
|
|
3
|
Miao CG, Yang YY, He X, Huang C, Huang Y,
Zhang L, Lv XW, Jin Y and Li J: The emerging role of microRNAs in
the pathogenesis of systemic lupus erythematosus. Cell Signal.
25:1828–1836. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma AR, Sharma G, Lee SS and
Chakraborty C: MiRNA-regulated key components of cytokine signaling
pathways and inflammation in rheumatoid arthritis. Med Res Rev.
36:425–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Habibi F, Ghadiri Soufi F, Ghiasi R,
Khamaneh AM and Alipour MR: Alteration in inflammation-related
miR-146a expression in NF-κB signaling pathway in diabetic rat
hippocampus. Adv Pharm Bull. 6:99–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stickel N, Prinz G, Pfeifer D, Hasselblatt
P, Schmitt-Graeff A, Follo M, Thimme R, Finke J, Duyster J, Salzer
U and Zeiser R: MiR-146a regulates the TRAF6/TNF-axis in donor T
cells during GVHD. Blood. 124:2586–2595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taganov KD, Boldin MP and Baltimore D:
MicroRNAs and immunity: Tiny players in a big field. Immunity.
26:133–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perl A: Pathogenic mechanisms in systemic
lupus erythematosus. Autoimmunity. 43:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang H, Peng W, Ouyang X, Li W and Dai Y:
Circulating microRNAs as candidate biomarkers in patients with
systemic lupus erythematosus. Transl Res. 160:198–206. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji JD, Cha ES and Lee WJ: Association of
miR-146a polymorphisms with systemic lupus erythematosus: A
meta-analysis. Lupus. 23:1023–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L,
Kalbfleisch JH, Gao X, Kao RL, Williams DL and Li C: Attenuation of
cardiac dysfunction in polymicrobial sepsis by MicroRNA-146a is
mediated via targeting of IRAK1 and TRAF6 expression. J Immunol.
195:672–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kaisho T and Aldra S: Toll-like receptor
function and signaling. J Allergy Clin Immunol. 117:979–988. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez-Pla A, Patel P, Maecker HT,
Rossello-Urgell J, Baldwin N, Bennett L, Cantrell V, Baisch J,
Punaro M, Gotte A, et al: IFN priming is necessary but not
sufficient to turn on a migratory dendritic cell program in lupus
monocytes. J Immunol. 192:5586–5598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang P, Han X, Mo B, Huang G and Wang C:
LPS enhances TLR4 expression and IFN-γ production via the
TLR4/IRAK/NF-κB signaling pathway in rat pulmonary arterial smooth
muscle cells. Mol Med Rep. 16:3111–3116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nahid MA, Pauley KM, Satoh M and Chan EK:
MiR-146a is critical for endotoxin-induced tolerance: Implication
in innate immunity. J Biol Chem. 284:34590–34599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Zeng Z, Shen X, Wu Z, Dong Y and
Cheng JC: MicroRNA-146a-5p negatively regulates pro-inflammatory
cytokine secretion and cell activation in lipopolysaccharide
stimulated human hepatic stellate cells through inhibition of
Toll-like receptor 4 signaling pathways. Int J Mol Sci1. 17(pii):
E10762016. View Article : Google Scholar
|
|
18
|
Muñoz LE, Janko C, Schulze C, Schorn C,
Sarter K, Schett G and Herrmann M: Autoimmunity and chronic
inflammation-two clearance-related steps in the etiopathogenesis of
SLE. Autoimmun Rev. 10:38–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan
YH, Xu ZM and Yin YB: Microarray analysis of microRNA expression in
peripheral blood cells of systemic lupus erythematosus patients.
Lupus. 16:939–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y,
Huang X, Zhou H, de Vries N, Tak PP, et al: MicroRNA-146A
contributes to abnormal activation of the type I interferon pathway
in human lupus by targeting the key signaling proteins. Arthritis
Rheum. 60:1065–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wigren M, Nilsson J and Kaplan MJ:
Pathogenic immunity in systemic lupus erythematosus and
atherosclerosis: Common mechanisms and possible targets for
intervention. J Intern Med. 278:494–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Means TK, Latz E, Hayashi F, Murali MR,
Golenbock DT and Luster AD: Human lupus autoantibody-DNA complexes
activate DCs through cooperation of CD32 and TLR9. J Clin Invest.
115:407–417. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Husakova M: MicroRNAs in the key events of
systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 160:327–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang H, Wang PF, Zhou Y, Wang YC and Yang
QW: Toll-like receptor 4 signaling in intracerebral
hemorrhage-induced inflammation and injury. J Neuroinflammation.
10:272013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He X, Zheng Y, Liu S, Shi S, Liu Y, He Y,
Zhang C and Zhou X: MiR-146a protects small intestine against
ischemia/reperfusion injury by down-regulatingTLR4/TRAF6/NF-κB
pathway. J Cell Physiol. 233:2476–2488. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nahid MA, Satoh M and Chan EK: MicroRNA in
TLR signaling and endotoxin tolerance. Cell Mol Immunol. 8:388–403.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Willis R, Seif AM, McGwin G Jr,
Martinez-Martinez LA, González EB, Dang N, Papalardo E, Liu J, Vilá
LM, Reveille JD, et al: Effect of hydroxychloroquine treatment on
pro-inflammatory cytokines and disease activity in SLE patients:
Data from LUMINA (LXXV), a multiethnic US cohort. Lupus.
21:830–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ripley BJ, Goncalves B, Isenberg DA,
Latchman DS and Rahman A: Raised levels of interleukin 6 in
systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis.
64:849–853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sabry A, Sheashaa H, EI-Husseini A,
Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM
and Abo-Zenah H: Proinflammatory cytokines (TNF-alpha and IL-6) in
Egyptian patients with SLE: Its correlation with disease activity.
Cytokine. 35:148–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arora V, Verma J, Marwah V, Kumar A, Anand
D and Das N: Cytokine imbalance in systemic lupus erythematosus: A
study on northern Indian subjects. Lupus. 21:596–603. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gigante A, Gasperini ML, Afeltra A,
Barbano B, Margiotta D, Cianci R, De Francesco I and Amoroso A:
Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci.
15:15–24. 2011.PubMed/NCBI
|
|
32
|
Robinson ES and Werth VP: The role of
cytokines in the pathogenesis of cutaneous lupus erythematosus.
Cytokine. 73:326–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nahid MA, Satoh M and Chan EK: Mechanistic
role of microRNA-146a in endotoxin-induced differential
cross-regulation of TLR signaling. J Immunol. 186:1723–1734. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Du L, Chen X, Duan Z, Liu C, Zeng R, Chen
Q and Li M: MiR-146a negatively regulatesdectin-1-induced
inflammatory responses. Oncotarget. 8:37355–37366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mookherjee N and El-Gabalawy HS: High
degree of correlation between whole blood and PBMC expression
levels of miR-155 and miR-146a in healthy controls and rheumatoid
arthritis patients. J Immunol Methods. 400-401:106–110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sheppard HM, Verdon D, Brooks AE, Feisst
V, Ho YY, Lorenz N, Fan V, Birch NP, Didsbury A and Dunbar PR:
MicroRNA regulation in human CD8+ T cell subsets-cytokine exposure
alone drives miR-146a expression. J Transl Med. 12:2922014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cho S, Lee HM, Yu IS, Choi YS, Huang HY,
Hashemifar SS, Lin LL, Chen MC, Afanasiev ND, Khan AA, et al:
Differential cell-intrinsic regulations of germinal center B and T
cells by miR-146a and miR-146b. Nat Commun. 9:27572018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu AM, Wang W and Luk JM: miRNAs: New
tools for molecular classification, diagnosis and prognosis of
hepatocellular carcinoma. Hepat Oncol. 1:323–329. 2014. View Article : Google Scholar : PubMed/NCBI
|
